Scinai Immunotherapeutics Ltd. (SCNI)
1.18
-0.03
(-2.48%)
USD |
NASDAQ |
Oct 09, 16:00
1.195
+0.02
(+1.27%)
After-Hours: 20:00
Scinai Immunotherapeutics EPS Diluted (Quarterly) : -3.662 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.662 |
| March 31, 2026 | 95.74 |
| December 31, 2025 | -60.37 |
| September 30, 2025 | -474.22 |
| June 30, 2025 | -175.70 |
| March 31, 2025 | -79.58 |
| December 31, 2024 | -262.07 |
| September 30, 2024 | 1243.68 |
| June 30, 2024 | -274.92 |
| March 31, 2024 | -432.75 |
| December 31, 2023 | -505.42 |
| September 30, 2023 | 661.64 |
| June 30, 2023 | -1098.88 |
| March 31, 2023 | -1073.85 |
| September 30, 2022 | 242.55 |
| June 30, 2022 | -2058.30 |
| March 31, 2022 | -2066.06 |
| December 31, 2021 | -2352.41 |
| September 30, 2021 | -1951.59 |
| June 30, 2021 | -2563.45 |
| March 31, 2021 | -1884.41 |
| December 31, 2020 | -3668.32 |
| September 30, 2020 | 12021.59 |
| June 30, 2020 | -11029.22 |
| March 31, 2020 | -1033.70 |
| Date | Value |
|---|---|
| December 31, 2019 | -12219.89 |
| September 30, 2019 | -5811.87 |
| June 30, 2019 | -20162.41 |
| March 31, 2019 | 238.27 |
| December 31, 2018 | -18914.01 |
| September 30, 2018 | -947.76 |
| June 30, 2018 | -10902.60 |
| March 31, 2018 | -6278.32 |
| December 31, 2017 | -5722.20 |
| September 30, 2017 | 1123.72 |
| June 30, 2017 | -7890.12 |
| March 31, 2017 | -7612.36 |
| December 31, 2016 | -2082.72 |
| September 30, 2016 | -2115.28 |
| June 30, 2016 | -2099.36 |
| March 31, 2016 | -1033.44 |
| December 31, 2015 | -2064.96 |
| September 30, 2015 | 102.25 |
| June 30, 2015 | -5215.60 |
| March 31, 2015 | -3027.84 |
| December 31, 2014 | -3108.84 |
| September 30, 2014 | -3373.80 |
| June 30, 2014 | -4632.00 |
| March 31, 2014 | -4572.32 |
| December 31, 2013 | -4566.08 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.074 |
| Pluri, Inc. | -0.5432 |
| Evogene Ltd. | -0.1449 |
| CollPlant Biotechnologies Ltd. | -1.890 |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.037M |
| Revenue (Quarterly) | 0.4679M |
| Total Expenses (Quarterly) | 2.505M |
| Enterprise Value | 7.027M |
| Gross Profit Margin (Quarterly) | -272.2% |
| Profit Margin (Quarterly) | -435.4% |
| Earnings Yield | -37.50K% |
| Normalized Earnings Yield | -18452.97 |